Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Associations among ancestry, geography and breast cancer incidence, mortality, and survival in Trinidad and Tobago

View through CrossRef
AbstractBreast cancer (BC) is the most common newly diagnosed cancer among women in Trinidad and Tobago (TT) and BC mortality rates are among the highest in the world. Globally, racial/ethnic trends in BC incidence, mortality and survival have been reported. However, such investigations have not been conducted in TT, which has been noted for its rich diversity. In this study, we investigated associations among ancestry, geography and BC incidence, mortality and survival in TT. Data on 3767 incident BC cases, reported to the National Cancer Registry of TT, from 1995 to 2007, were analyzed in this study. Women of African ancestry had significantly higher BC incidence and mortality rates (Incidence: 66.96; Mortality: 30.82 per 100,000) compared to women of East Indian (Incidence: 41.04, Mortality: 14.19 per 100,000) or mixed ancestry (Incidence: 36.72, Mortality: 13.80 per 100,000). Geographically, women residing in the North West Regional Health Authority (RHA) catchment area followed by the North Central RHA exhibited the highest incidence and mortality rates. Notable ancestral differences in survival were also observed. Women of East Indian and mixed ancestry experienced significantly longer survival than those of African ancestry. Differences in survival by geography were not observed. In TT, ancestry and geographical residence seem to be strong predictors of BC incidence and mortality rates. Additionally, disparities in survival by ancestry were found. These data should be considered in the design and implementation of strategies to reduce BC incidence and mortality rates in TT.
Title: Associations among ancestry, geography and breast cancer incidence, mortality, and survival in Trinidad and Tobago
Description:
AbstractBreast cancer (BC) is the most common newly diagnosed cancer among women in Trinidad and Tobago (TT) and BC mortality rates are among the highest in the world.
Globally, racial/ethnic trends in BC incidence, mortality and survival have been reported.
However, such investigations have not been conducted in TT, which has been noted for its rich diversity.
In this study, we investigated associations among ancestry, geography and BC incidence, mortality and survival in TT.
Data on 3767 incident BC cases, reported to the National Cancer Registry of TT, from 1995 to 2007, were analyzed in this study.
Women of African ancestry had significantly higher BC incidence and mortality rates (Incidence: 66.
96; Mortality: 30.
82 per 100,000) compared to women of East Indian (Incidence: 41.
04, Mortality: 14.
19 per 100,000) or mixed ancestry (Incidence: 36.
72, Mortality: 13.
80 per 100,000).
Geographically, women residing in the North West Regional Health Authority (RHA) catchment area followed by the North Central RHA exhibited the highest incidence and mortality rates.
Notable ancestral differences in survival were also observed.
Women of East Indian and mixed ancestry experienced significantly longer survival than those of African ancestry.
Differences in survival by geography were not observed.
In TT, ancestry and geographical residence seem to be strong predictors of BC incidence and mortality rates.
Additionally, disparities in survival by ancestry were found.
These data should be considered in the design and implementation of strategies to reduce BC incidence and mortality rates in TT.

Related Results

Abstract B46: Cancer incidence and mortality rates and trends in Trinidad and Tobago
Abstract B46: Cancer incidence and mortality rates and trends in Trinidad and Tobago
Abstract Background: Consistent with observations from various developing regions of the world, cancer incidence and mortality rates have increased in the past two d...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Offshore Mahogany Field Development to Support Trinidad's LNG Plant
Offshore Mahogany Field Development to Support Trinidad's LNG Plant
Abstract In the mid-1990's, BP Amoco embarked on an accelerated exploration programme offshore Trinidad, discovering in excess of 10 Tscf gas reserves. This led i...
Investigation of triple negative breast cancer rates in women diagnosed with breast cancer in Trinidad and Tobago.
Investigation of triple negative breast cancer rates in women diagnosed with breast cancer in Trinidad and Tobago.
e19005 Background: According to the WHO/PAHO, Trinidad and Tobago (T&T) has the 2nd highest breast cancer mortality rate in the Caribbean region. In T&T, citizens of Afric...
Development of a Thornthwaite Moisture Index Map for Trinidad and Tobago
Development of a Thornthwaite Moisture Index Map for Trinidad and Tobago
The Thornthwaite Moisture Index (TMI) has been traditionally used as a climatic index parameter to estimate annual moisture status of soils (deficit/surplus), primarily in the agri...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...

Back to Top